Coobi Secures $500K in Pre-Seed Funding to Transform Digital Addiction Aftercare with ML Technology

We're thrilled to announce that coobi has successfully raised $500,000 in our latest funding round—a significant milestone that will propel our mission forward and empower us to revolutionize addiction treatment. At coobi, we are driven by our commitment to using cutting-edge technology to make treatment and support for addiction more accessible and efficient. This infusion of capital will enable us to accelerate the development of our novel, machine learning-based algorithm that leverages digital biomarkers gathered from smartphones and wearable devices. By analyzing these biomarkers, our algorithm calculates the individual risk of relapse, providing objective insights into addictive behaviors that can be critical for tailored, effective care. The funds will be strategically invested in refining our digital aftercare platform, ensuring that it not only meets the highest standards of accuracy and usability but also expands its reach to individuals in need of innovative support in managing substance-based addiction. As we continue to enhance our technology, we are committed to fostering an ecosystem where healthcare providers, patients, and caregivers have access to data-driven tools that facilitate early intervention and continuous support throughout the rehabilitation journey. This funding marks an important step toward fulfilling our vision of redefining how addiction care is delivered, ultimately leading to better outcomes and more sustainable recovery paths. We are excited to build on this momentum and invite you to follow our journey as we work tirelessly to create a future where state-of-the-art digital aftercare empowers millions battling addiction. For additional details on our initiative and progress, please visit https://www.coobi.health/.